Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - SpectRx, Inc. (NasdaqNM:SPRX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
6025A Unity Drive
Norcross, GA 30071
Phone: (770) 242-8723
Fax: (770) 242-8639
Email: iskillen@spectrx.com
Employees (last reported count): 70
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 53%
·Over the last 6 months:
 · one insider buy; 1,000  shares
·Institutional: 22% (47% of float)
(22 institutions)
·Net Inst. Buying: 1.93M shares (+45.83%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
SpectRx, Inc. is a specialty point-of-care medical diagnostics company that employs biophotonic technologies to provide painless, non-invasive and minimally invasive alternatives to blood and tissue sampling procedures. Biophotonic technology is the use of light and other forms of energy to access the human body to diagnose and monitor disease. The Company has developed a product that provides a non-invasive alternative to the conventional blood test for detecting and monitoring infant jaundice. The Company is also developing products that it believes will provide less invasive and painless alternatives to products that are currently available for conventional diabetes detection, glucose monitoring and cancer detection.
More from Market Guide: Expanded Business Description

Financial Summary
SPRX is engaged in the research and development of products that offer less invasive and painless alternatives to blood tests currently used for glucose monitoring, diabetes screening and infant jaundice. For the six months ended 6/30/01, revenues fell 33% to $1.3 million. Net loss applicable to Common decreased 4% to $3.8 million. Results reflect reduced collaborative agreement revenues, offset by lower research and development expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Mark Samuels, 42
Chairman, CEO
$286K$0.6K
Keith Ignotz, 53
Pres and COO
224K--  
Thomas Muller, Jr., 59
CFO, Exec. VP, Sec.
202K--  
Robert Rothfritz, 51
VP of Operations
--  --  
Richard Fowler, 44
VP of Technology Assessment
131K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SPRXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 9-Apr-2001
$5.05 
Recent Price$7.55 
52-Week High
on 5-Oct-2000
$11.25 
Beta0.63 
Daily Volume (3-month avg)2,682 
Daily Volume (10-day avg)5,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-2.6%
52-Week Change
relative to S&P500
+30.7%
Share-Related Items
Market Capitalization$78.7M
Shares Outstanding10.4M
Float4.90M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.61 
Earnings (ttm)-$0.76 
Earnings (mrq)-$0.16 
Sales (ttm)$0.51 
Cash (mrq)$1.17 
Valuation Ratios
Price/Book (mrq)12.43 
Price/EarningsN/A 
Price/Sales (ttm)14.95 
Income Statements
Sales (ttm)$4.36M
EBITDA (ttm)-$6.03M
Income available to common (ttm)-$6.51M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-73.10%
Return on Equity (ttm)-1392.17%
Financial Strength
Current Ratio (mrq)5.42 
Debt/Equity (mrq)0 
Total Cash (mrq)$12.2M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume3,000 
See Profile Help for a description of each item above;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.